Barrett Elizabeth A.

CIK 00017641574 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001764157

Recent Transactions

50 trades

Award
Allogene Therapeutics, Inc.$ALLO
Restricted Stock Unit
2026-06-18+95,400→ 95,400 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2026-01-31+153,195→ 153,195 total
Disposition from Tender
Sage Therapeutics, Inc.
Common Stock
2025-07-31−3,000→ 0 total
Disposition to Issuer
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-31−21,500→ 0 total
Award
UroGen Pharma Ltd.$URGN
Performance Stock Units
2025-07-28+87,615→ 87,615 total
Award
Allogene Therapeutics, Inc.$ALLO
Restricted Stock Unit
2025-06-18+95,400→ 95,400 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2025-06-11+21,500→ 21,500 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2025-01-31+96,377→ 96,377 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2024-06-05+191,082→ 191,082 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2024-01-31+87,615→ 87,615 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2023-06-13+116,120→ 116,120 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-01-31−13,333→ 13,334 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-01-31+75,000→ 75,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-01-31+13,333→ 326,691 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2023-01-31−5,000→ 0 total
Award
UroGen Pharma Ltd.$URGN
Performance Stock Units
2023-01-31+100,000→ 100,000 total
Award
UroGen Pharma Ltd.$URGN
Employee Stock Option (right to buy)
2023-01-31+125,000→ 125,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2023-01-31+5,000→ 313,358 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2022-06-15+71,070→ 71,070 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-01-31+13,333→ 314,318 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2022-01-31−5,000→ 5,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-01-31+5,000→ 303,220 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-01-31$7.58/sh−2,235→ 300,985 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-01-31$7.58/sh−5,960→ 308,358 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2022-01-31+150,000→ 150,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2022-01-31−13,333→ 26,667 total
Sale
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-01-04$9.15/sh−46,968→ 298,220 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-01-03+105,689→ 345,188 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2022-01-03−105,689→ 0 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-07-30+63,385→ 63,385 total
Tax Payment
UroGen Pharma Ltd.$URGN
Ordinary Shares
2021-05-19$17.51/sh−1,240→ 239,499 total
Tax Payment
UroGen Pharma Ltd.$URGN
Ordinary Shares
2021-05-19$17.51/sh−2,185→ 240,739 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2021-01-31−5,000→ 10,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2021-01-31+5,000→ 242,924 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2021-01-31+150,000→ 150,000 total
Award
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2021-01-31+40,000→ 40,000 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2021-01-03−8,807→ 105,689 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2021-01-03+8,807→ 237,924 total
Purchase
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-12-14$18.50/sh+10,000→ 229,117 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-12-04+61,652→ 219,117 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-12-04−61,652→ 114,496 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-12-03+8,808→ 219,117 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-12-03−8,808→ 114,496 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-11-03+8,808→ 210,309 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-11-03−8,808→ 123,304 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-10-03−8,808→ 132,112 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-10-03+8,808→ 201,501 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Restricted Stock Units
2020-09-03−8,807→ 140,920 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-09-03+8,807→ 192,693 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2020-08-03+8,807→ 183,886 total

Companies

Recent Filings

Address

210 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov